Connection

Yongqiang Wang to Animals

This is a "connection" page, showing publications Yongqiang Wang has written about Animals.
Connection Strength

0.067
  1. Probing and Enhancing Ligand-Mediated Active Targeting of Tumors Using Sub-5 nm Ultrafine Iron Oxide Nanoparticles. Theranostics. 2020; 10(6):2479-2494.
    View in: PubMed
    Score: 0.013
  2. Exerting Enhanced Permeability and Retention Effect Driven Delivery by Ultrafine Iron Oxide Nanoparticles with T1-T2 Switchable Magnetic Resonance Imaging Contrast. ACS Nano. 2017 05 23; 11(5):4582-4592.
    View in: PubMed
    Score: 0.011
  3. Preclinical evaluation of a urokinase plasminogen activator receptor-targeted nanoprobe in rhesus monkeys. Int J Nanomedicine. 2015; 10:6689-98.
    View in: PubMed
    Score: 0.010
  4. Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer. ACS Nano. 2014 Jul 22; 8(7):6620-32.
    View in: PubMed
    Score: 0.009
  5. Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells. Prostate. 2013 Nov; 73(15):1681-9.
    View in: PubMed
    Score: 0.009
  6. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer. ACS Nano. 2013 Mar 26; 7(3):2078-89.
    View in: PubMed
    Score: 0.008
  7. Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PgammaMPS copolymer coating. Biomaterials. 2010 Jul; 31(20):5397-407.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.